Skip to content

Homeopathic treatment of thyroid disorders in children and adults

A double-blind, randomized, placebo-controlled trial evaluating add-on individualized homoeopathic medicines to standard care in improving signs and symptoms of hypothyroidism in children and adults

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/04/051311
Enrollment
64
Registered
2023-04-05
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E039- Hypothyroidism, unspecified

Interventions

Intervention1: Individualized Homeopathic Medicines plus standard care: Intervention is planned as administering levothyroxine therapy plus individualized homeopathic medicines. It is usually started
dosage and repetition depending upon the individual requirement of the cases. Patients will be advised to refrain from handling the globules or from eating , drinking ,smoking or brushing teeth wit
dosage and repetition will be

Sponsors

D N De Homoeopathic Medical College Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients suffering from hypothyroidism [ICD â??E03.9], newly diagnosed cases with serum TSH more than 10 µIU/ml), confirmed by biochemical tests 2) Age between 10 and 65 years 3) Patients of either sex or transgender 4) Providing with written informed consent and/or assent 5) Illiterate people will be interviewed by the investigators maintaining adequate privacy to fill up the scales or questionnaire.

Exclusion criteria

Exclusion criteria: 1. Patients suffering from congenital hypothyroidism, subclinical hypothyroidism . 2. Vulnerable population - Unconscious, non-ambulatory, too sick for consultation, disabled, terminally ill or critically ill patients, mentally incompetent people 3. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any organ failure. 4.Pregnant and puerperal women, lactating mothers 5. Patients with the habit of tobacco chewing and/or smoking, alcoholism and/or any other form(s) of substance abuse and/or dependence. 6.Self-reported immune-compromised state 7.Already undergoing homeopathic treatment for chronic disease within last 6 months. 8. Simultaneous participation in any other clinical trial

Design outcomes

Primary

MeasureTime frame
Zulewski clinical scoreTimepoint: Baseline, every month, up to 3 months

Secondary

MeasureTime frame
Serum TSH, T3, and T4Timepoint: Baseline and after 3 months;Thyroid specific patient reported outcomesTimepoint: Baseline, every month, up to 3 months

Countries

India

Contacts

Public ContactMd Sakhawat Hossain

D N De Homoeopathic Medical College & Hospital

imdrmsh@gmail.com9433852961

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026